Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph A DiMasi

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Pharmacoeconomics|November 30, 2002
The value of improving the productivity of the drug development process: faster times and better decisionsJoseph A DiMasi
American Journal of Therapeutics|September 1, 1996
A New Look At United States Drug Development and Approval TimesJoseph A. DiMasi
Clinical Therapeutics|June 4, 2013
Innovating by developing new uses of already-approved drugs: trends in the marketing approval of supplemental indicationsJoseph A DiMasi
Health Affairs (Project Hope)|July 13, 2006
What's time got to do with it?Joseph A DiMasi
American Journal of Therapeutics|January 25, 2013
Pharmaceutical R&D performance by firm size: approval success rates and economic returnsJoseph A DiMasi
JAMA Internal Medicine|April 4, 2018
Assessing Pharmaceutical Research and Development CostsJoseph A DiMasi
JAMA|August 5, 2020
Research and Development Costs of New DrugsJoseph A DiMasi
Therapeutic Innovation & Regulatory Science|June 6, 2020
The Financial Benefits of Faster Development Times: Integrated Formulation Development, Real-Time Manufacturing, and Clinical TestingJoseph A DiMasi, Michael Wilkinson
Pharmacoeconomics|January 22, 2005
The economics of follow-on drug research and development: trends in entry rates and the timing of developmentJoseph A DiMasi, Cherie Paquette
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 2007
Economics of new oncology drug developmentJoseph A DiMasi, Henry G Grabowski
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Pharmacoeconomics|November 30, 2002
The value of improving the productivity of the drug development process: faster times and better decisionsJoseph A DiMasi
American Journal of Therapeutics|September 1, 1996
A New Look At United States Drug Development and Approval TimesJoseph A. DiMasi
Clinical Therapeutics|June 4, 2013
Innovating by developing new uses of already-approved drugs: trends in the marketing approval of supplemental indicationsJoseph A DiMasi
Health Affairs (Project Hope)|July 13, 2006
What's time got to do with it?Joseph A DiMasi
American Journal of Therapeutics|January 25, 2013
Pharmaceutical R&D performance by firm size: approval success rates and economic returnsJoseph A DiMasi
JAMA Internal Medicine|April 4, 2018
Assessing Pharmaceutical Research and Development CostsJoseph A DiMasi
JAMA|August 5, 2020
Research and Development Costs of New DrugsJoseph A DiMasi
Therapeutic Innovation & Regulatory Science|June 6, 2020
The Financial Benefits of Faster Development Times: Integrated Formulation Development, Real-Time Manufacturing, and Clinical TestingJoseph A DiMasi, Michael Wilkinson
Pharmacoeconomics|January 22, 2005
The economics of follow-on drug research and development: trends in entry rates and the timing of developmentJoseph A DiMasi, Cherie Paquette
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 2007
Economics of new oncology drug developmentJoseph A DiMasi, Henry G Grabowski
Pageof 4